First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.
Pamela MunsterMonica MitaAmit MahipalJohn NemunaitisChristophe MassardTom MikkelsenCristina CruzLuis G Paz-AresManuel HidalgoDana RathkopfGeorge BlumenscheinDavid C SmithBarbara EichhorstTim CloughesyEllen H FilvaroffShaoyi LiHeather RaymonHans de HaanKristen HegeJohanna C BendellPublished in: Cancer management and research (2019)
NCT01353625.